All News hVIVO plc

Equities

Delayed London S.E. Other stock markets 06:26:13 2024-05-10 am EDT			5-day change	1st Jan Change
27.88 ^GBX	-0.45%		-0.45%	+17.37%

Apr. 09	Transcript : HVIVO plc, 2023 Earnings Call, Apr 09, 2024
Apr. 09	HVIVO plc Provides Revenue Guidance for the Year 2024	CI

Transcript : HVIVO plc, 2023 Earnings Call, Apr 09, 2024	Apr. 09
HVIVO swings to profit and commences annual dividends as outlook rosy	Apr. 09	AN
HVIVO plc Provides Revenue Guidance for the Year 2024	Apr. 09	CI
Transcript : HVIVO plc, 2023 Earnings Call, Apr 09, 2024	Apr. 09
HVIVO plc Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 09	CI
European Green Transition starts trading on London's AIM market	Apr. 08	AN
Investment firm European Green Transition plans listing on AIM	Mar. 18	AN
HVIVO Chair and non-exec director sell 30.0 million shares	Feb. 14	AN
Hvivo Completes Secondary Placing	Feb. 14	MT
HVIVO directors to sell total of 14 million shares	Feb. 14	AN
Hvivo Shareholders Plan Secondary Placing to Sell 14 Million Shares	Feb. 14	MT
Transcript : HVIVO plc, Q4 2023 Sales/ Trading Statement Call, Jan 30, 2024	Jan. 30
FTSE 100 Ends on Three-Week High, Partly on Diageo Rebound	Jan. 30	DJ
HVIVO shares up after "record year" across all metrics	Jan. 30	AN
Hvivo Wins GBP6 Million Antiviral Testing Contract	Jan. 02	MT
HVIVO inks GBP6.3 million deal to test common cold treatment	Jan. 02	AN
New Year begins largely green amid slew of PMIs	Jan. 02	AN
HVIVO plc Signs £6.3 Million Human Challenge Study Model	Jan. 02	CI
Hvivo Secures GBP17 Million Contract for RSV Antiviral Drug Testing; Stock Surges	Dec. 13	MT
HVIVO signs deal to test RSV antiviral drug candidate with study model	Dec. 13	AN

No results for this search